Follow The Filings

KZIA Kazia Therapeutics

Health Care, filed as KAZIA THERAPEUTICS (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $704K
  • 1 new

In 2026 Q2 Leon Cooperman opened a position in Kazia Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Leon Cooperman, Omega Advisors). Not free-float ownership.

  1. Leon Cooperman New 0.02%

Who owns KZIA

Sorted by value, long equity only, as of 2026 Q2.

History
Leon Cooperman, Omega Advisors 0.02% New 0.02% 50,000 $704K History

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
6-K REPORT OF FOREIGN PRIVATE ISSUER
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
6-K REPORT OF FOREIGN PRIVATE ISSUER
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
6-K REPORT OF FOREIGN PRIVATE ISSUER
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B5 PROSPECTUS SUPPLEMENT
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B5 PROSPECTUS SUPPLEMENT
6-K REPORT OF FOREIGN PRIVATE ISSUER

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jan 8, 2026

Financials

US-GAAP annual figures, as tagged in Form 10-K

Newly public, no 10-K financials yet. See the 424B3.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Period archive